CoChat

Immune‐related adverse reactions in the hepatobiliary system: second‐generation check‐point inhibitors highlight diverse histological changes

Zen, Yoh, Chen, Yen‐Ying, Jeng, Yung‐Ming, Tsai, Hung‐Wen, Yeh, Matthew M · 2020 · Histopathology
Cited by 83

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Aims: Immune check‐point inhibitors are known to cause immune‐mediated adverse liver injury, but our knowledge is mainly based on cases treated with ipilimumab or nivolumab. Methods and results: Clinicopathological features of 10 patients with hepatobiliary adverse reactions caused by second‐generation drugs, pembrolizumab (n = 6) and atezolizumab (n = 4), were reviewed. Liver dysfunction developed during a median period of 3.5 weeks after administration of the check‐point inhibitor (3 days–1 year). Antinuclear antibodies were detected in two patients at a low titre (1/80), and serum IgG concentrations were also only mildly elevated in two patients. Liver biopsies showed panlobular hepatitis (n = 5), cholangiopathic changes (n = 2), granulomatous injury (n = 2) and bland cholestasis (n = 1). Two cases of cholangiopathy (both pembrolizumab‐treated) showed diffuse sclerosing cholangitis on imaging, and one also presented lymphocytic cholangitis resembling primary biliary cholangitis on biopsy. In two atezolizumab‐treated cases, Küpffer cells were hyperplastic and aggregated, forming microgranulomas. Confluent necrosis and eosinophilic or plasma cell infiltration were rare. On immunostaining, the ratio of CD8+/CD4+ cells was 12.2 ± 5.1, which was significantly higher than that in autoimmune hepatitis (2.7 ± 1.1; P < 0.001) or idiosyncratic drug‐induced liver injury (5.0 ± 1.1; P = 0.014). All patients responded to steroid therapy, but it was less effective in patients with sclerosing cholangitis. Conclusions: Pembrolizumab and atezolizumab manifested not only lobular hepatitis but also sclerosing cholangitis, lymphocytic duct injury and granulomatous hepatitis, probably representing various impaired cellular functions in CD8+ lymphocytes and macrophages due to blockage of PD‐1–PD‐L1 interaction.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/his.14000

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 24

  1. 10.1056/NEJMoa1200690 · DOI · Paper page
  2. 10.1200/JCO.2014.60.0379 · DOI · Paper page
  3. 10.1056/NEJMoa1606774 · DOI · Paper page
  4. 10.1056/NEJMoa1501824 · DOI · Paper page
  5. 10.1038/s41379-018-0013-y · DOI · Paper page
  6. 10.1097/PAS.0000000000000453 · DOI · Paper page
  7. 10.1007/s10620-012-2140-5 · DOI · Paper page
  8. 10.1002/hep.30157 · DOI · Paper page
  9. 10.1016/j.pathol.2017.07.010 · DOI
  10. 10.1136/gutjnl-2016-313369 · DOI · Paper page
  11. 10.1053/j.semdp.2019.07.009 · DOI · Paper page
  12. 10.1056/NEJMoa1504030 · DOI · Paper page
  13. 10.1093/annonc/mdq013 · DOI · Paper page
  14. 10.1055/s-0036-1584319 · DOI
  15. 10.1097/01.pas.0000136449.37936.6c · DOI · Paper page
  16. 10.1007/s00535-016-1163-7 · DOI
  17. 10.1007/s10637-017-0453-0 · DOI · Paper page
  18. 10.1097/PAS.0000000000000759 · DOI · Paper page
  19. 10.1159/000362614 · DOI · Paper page
  20. 10.4161/21624011.2014.954506 · DOI · Paper page
  21. 10.1200/JCO.2011.39.3298 · DOI · Paper page
  22. 10.1016/j.jhep.2018.01.033 · DOI · Paper page
  23. 10.1189/jlb.0113051 · DOI
  24. 10.1371/journal.pone.0158265 · DOI

Cited by

See all 83

Metadata

Authors
Zen, Y., Chen, Y., Jeng, Y., Tsai, H., & Yeh, M. M.
Affiliations
  • Institute of Liver Studies King's College Hospital and King's College London London UK
  • Department of Pathology and Laboratory Medicine Taipei Veterans General Hospital Taipei Taiwan
  • Department of Pathology National Taiwan University Taipei Taiwan
  • Department of Pathology National Cheng‐Kung University Tainan Taiwan
  • Department of Pathology University of Washington School of Medicine Seattle WA USA
Venue
Histopathology
Publisher
Wiley
Published
2019-12
Volume
76
Issue
3
Pages
470-480
ISSN
  • 0309-0167
  • 1365-2559
Cited by
83
References
6
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Immune‐related adverse reactions in the hepatobiliary system: second‐generation check‐point inhibitors highlight diverse histological changes. https://app.cochat.ai/papers/10.1111/his.14000
The paper
Zen, Y., Chen, Y., Jeng, Y., Tsai, H., & Yeh, M. M. (2020). Immune‐related adverse reactions in the hepatobiliary system: second‐generation check‐point inhibitors highlight diverse histological changes. Histopathology. https://doi.org/10.1111/his.14000

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.